New Blood Test Detects Drug-Induced Tissue Damage in Cancer Patients Early
A blood test identifies early lung damage in cancer patients taking antibody–drug conjugates, offering an alternative to imaging scans.
Read MorePosted by Andy Lundin | Nov 12, 2024 | Lung Cancer |
A blood test identifies early lung damage in cancer patients taking antibody–drug conjugates, offering an alternative to imaging scans.
Read MorePosted by Andy Lundin | Nov 7, 2024 | Cancer |
Caris Life Sciences’ MI Cancer Seek CDx assay received FDA approval to help identify cancer patients who may benefit from targeted therapies.
Read MorePosted by Andy Lundin | Nov 7, 2024 | Diagnostic Technologies, Lung Cancer |
The system enables detection and personalized care for diseases like Cystic Fibrosis, Chronic Obstructive Pulmonary Diseases, and lung cancer.
Read MorePosted by Andy Lundin | Nov 6, 2024 | Lung Cancer |
Researchers developed a sensor that can detect low levels of isoprene in exhaled breath, potentially enabling early lung cancer diagnosis.
Read MorePosted by Chris Wolski | Oct 31, 2024 | Cancer |
Scientists at deCODE genetics/Amgen and their collaborators have identified six new genes with rare germline variants linked to cancer risk.
Read More